BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
5/17/19 AbbVie (ABBV) Depatuxizumab Mafodotin for Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM)) Subscribers Only Subscribers Only Subscribers Only
5/15/19 Agios (AGIO) Tibsovo for Biliary Tract Cancer Subscribers Only Subscribers Only Subscribers Only
5/15/19 Advaxis (ADXS) Axalimogene Filolisbac for Cervical Cancer Subscribers Only Subscribers Only Subscribers Only
5/15/19 Gore GORE TAG Thoracic Endoprosthesis for Aortic Aneurysm Subscribers Only Subscribers Only Subscribers Only
5/15/19 Bristol-Myers Squibb (BMY) Opdivo for Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
05/18/19 Subscribers Only Subscribers Only Trial Data - Top-Line Results
05/18/19 Subscribers Only Subscribers Only Trial Data - Updated Results
05/19/19 Subscribers Only Subscribers Only Trial Data - Other
05/19/19 Subscribers Only Subscribers Only Trial Data - Other
05/19/19 Subscribers Only Subscribers Only Trial Data - Other
Back to the top Back to the top